Focuses on the interface of organic synthesis and medicinal chemistry, leveraging organoboron scaffolds, de novo library design, and covalent ligand screening to create selective enzyme modulators. Combines multicomponent reactions and activity-based profiling to deliver peptidomimetics and chemical probes for drug discovery.